Cardiologists' practices compared with practice guidelines: use of beta-blockade after acute myocardial infarction

Center for Health Care Policy and Evaluation and Medical Services Group, United HealthCare Corporation, Minneapolis, Minnesota, USA.

OBJECTIVE: Our purpose was to measure cardiologists' level of adherence to guidelines for long-term use of beta-adrenergic blocker therapy after acute myocardial infarction. BACKGROUND: Beta-blocker therapy after acute myocardial infarction has been shown to reduce the incidence of reinfarction and associated mortality. To learn about cardiologists' use of this therapy after hospital discharge and their level of adherence to American College of Cardiology guidelines, we analyzed insurance claims from 17 network-model health plans located throughout the United States. METHODS: The study group included 150 cardiologists who had contracts with one of the health plans and their 280 patients who were plan members (excluding Medicare enrollees) and received inpatient treatment for acute myocardial infarction that did not include revascularization during 1992. These patients accounted for 307 separate hospital admissions. Insurance claims were used to measure beta-blocker usage and to identify possible contraindications. RESULTS: Forty-three percent of the cases (131 of 307) involved apparent deviations from the guidelines: 11% of cases (35 of 307) involved possible errors of commission (beta-blocker given in the presence of a contraindication) and 31% (96 of 307) errors of omission (beta-blocker not given in the absence of a contraindication). Of the 185 patients who were eligible for the therapy (no contraindications), only 48% (89 of 185) were treated. CONCLUSIONS: Cardiologists currently exhibit a low level of compliance with their specialty's guidelines for postinfarction beta-blockade. Slightly fewer than 50% of the study patients who were eligible for treatment actually received a beta-blocker after hospital discharge. This result, combined with the drug's known level of effectiveness in preventing recurrent myocardial infarction, suggests that increased use could avert approximately 1,900 deaths annually nationwide.

This article has been cited by other articles:

				P. C. Austin PhD, J. V. Tu MD PhD, D. T. Ko MD MSc, and D. A. Alter MD PhD Use of evidence-based therapies after discharge among elderly patients with acute myocardial infarction Can. Med. Assoc. J., October 21, 2008; 179(9): 895 - 900. [Abstract] [Full Text] [PDF]

				P. M. Colletti Coronary CT Angiography Without {beta}-Blockers Am. J. Roentgenol., December 1, 2007; 189(6): 1324 - 1325. [Full Text] [PDF]

				C. Rosendorff, H. R. Black, C. P. Cannon, B. J. Gersh, J. Gore, J. L. Izzo Jr, N. M. Kaplan, C. M. O'Connor, P. T. O'Gara, and S. Oparil REPRINT Treatment of Hypertension in the Prevention and Management of Ischemic Heart Disease: A Scientific Statement From the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention Hypertension, August 1, 2007; 50(2): e28 - e55. [Full Text] [PDF]

				C. Rosendorff, H. R. Black, C. P. Cannon, B. J. Gersh, J. Gore, J. L. Izzo Jr, N. M. Kaplan, C. M. O'Connor, P. T. O'Gara, and S. Oparil Treatment of Hypertension in the Prevention and Management of Ischemic Heart Disease: A Scientific Statement From the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention Circulation, May 29, 2007; 115(21): 2761 - 2788. [Full Text] [PDF]

				A. W Fernandes, S S. Madhavan, M. M Amonkar, D. Bell, S. S Islam, and V. G Scott Outcomes of Inappropriate Prescribing of {beta}-Blockers After an Acute Myocardial Infarction in a Medicaid Population Ann. Pharmacother., September 1, 2005; 39(9): 1416 - 1422. [Abstract] [Full Text] [PDF]

				P. D. Sloane, A. L. Gruber-Baldini, S. Zimmerman, M. Roth, L. Watson, M. Boustani, J. Magaziner, and J. R. Hebel Medication Undertreatment in Assisted Living Settings Arch Intern Med, October 11, 2004; 164(18): 2031 - 2037. [Abstract] [Full Text] [PDF]

				M. R Andrus, K. P Holloway, and D. B Clark Use of {beta}-Blockers in Patients with COPD Ann. Pharmacother., January 1, 2004; 38(1): 142 - 145. [Abstract] [Full Text] [PDF]

				J. E. Freedman, R. C. Becker, J. E. Adams, S. Borzak, R. L. Jesse, L. K. Newby, P. O'Gara, J. C. Pezzullo, R. Kerber, B. Coleman, et al. Medication Errors in Acute Cardiac Care: An American Heart Association Scientific Statement From the Council on Clinical Cardiology Subcommittee on Acute Cardiac Care, Council on Cardiopulmonary and Critical Care, Council on Cardiovascular Nursing, and Council on Stroke Circulation, November 12, 2002; 106(20): 2623 - 2629. [Full Text] [PDF]

				M. Zaugg, M. C. Schaub, T. Pasch, and D. R. Spahn Modulation of {beta}-adrenergic receptor subtype activities in perioperative medicine: mechanisms and sites of action Br. J. Anaesth., January 1, 2002; 88(1): 101 - 123. [Abstract] [Full Text] [PDF]

				E. Skof, M. Span, and I. Keber Secondary Prevention in Patients Several Years after Myocardial Infarction: Comparison of an Outpatient and an Inpatient Rehabilitation Programme European Journal of Cardiovascular Prevention & Rehabilitation, June 1, 2001; 8(3): 119 - 126. [Abstract] [PDF]

				M.-D. Beaulieu, R. Blais, A. Jacques, R.N. Battista, R. Lebeau, and J. Brophy Are patients suffering from stable angina receiving optimal medical treatment? QJM, June 1, 2001; 94(6): 301 - 308. [Abstract] [Full Text] [PDF]

				E. H. Bradley, E. S. Holmboe, J. A. Mattera, S. A. Roumanis, M. J. Radford, and H. M. Krumholz A Qualitative Study of Increasing {beta}-Blocker Use After Myocardial Infarction: Why Do Some Hospitals Succeed? JAMA, May 23, 2001; 285(20): 2604 - 2611. [Abstract] [Full Text] [PDF]

				C. A. Jackevicius, G. M. Anderson, L. Leiter, and J. V. Tu Use of the Statins in Patients After Acute Myocardial Infarction: Does Evidence Change Practice? Arch Intern Med, January 22, 2001; 161(2): 183 - 188. [Abstract] [Full Text] [PDF]

				K. A. Phillips, M. G. Shlipak, P. Coxson, P. A. Heidenreich, M. G. M. Hunink, P. A. Goldman, L. W. Williams, M. C. Weinstein, and L. Goldman Health and Economic Benefits of Increased {beta}-Blocker Use Following Myocardial Infarction JAMA, December 6, 2000; 284(21): 2748 - 2754. [Abstract] [Full Text] [PDF]

				R. H. Mehta, S. Das, T. T. Tsai, E. Nolan, G. Kearly, and K. A. Eagle Quality Improvement Initiative and Its Impact on the Management of Patients With Acute Myocardial Infarction Arch Intern Med, November 13, 2000; 160(20): 3057 - 3062. [Abstract] [Full Text] [PDF]

				I. Sim, D. K. Owens, P. W. Lavori, and G. D. Rennels Electronic Trial Banks: A Complementary Method for Reporting Randomized Trials Med Decis Making, October 1, 2000; 20(4): 440 - 450. [Abstract] [PDF]

				C. H. MacLean, R. Louie, B. Leake, D. F. McCaffrey, H. E. Paulus, R. H. Brook, and P. G. Shekelle Quality of Care for Patients With Rheumatoid Arthritis JAMA, August 23, 2000; 284(8): 984 - 992. [Abstract] [Full Text] [PDF]

				G. W. Vetrovec Acute and Delayed Benefits of {beta}-Blockers During Coronary Intervention : True, True and Unrelated Circulation, July 11, 2000; 102(2): 147 - 148. [Full Text] [PDF]

				M. J. Kucenic, D. G. Meyers, and D. G. Meyers Impact of a Clinical Pathway on the Care and Costs of Myocardial Infarction Angiology, May 1, 2000; 51(5): 393 - 404. [Abstract] [PDF]

				C. D. Frances, A. S. Go, K. W. Dauterman, K. Deosaransingh, D. L. Jung, S. Gettner, J. M. Newman, B. M. Massie, and W. S. Browner Outcome Following Acute Myocardial Infarction: Are Differences Among Physician Specialties the Result of Quality of Care or Case Mix? Arch Intern Med, July 12, 1999; 159(13): 1429 - 1436. [Abstract] [Full Text] [PDF]

				D. McCormick, J. H. Gurwitz, D. Lessard, J. Yarzebski, J. M. Gore, and R. J. Goldberg Use of Aspirin, {beta}-Blockers, and Lipid-Lowering Medications Before Recurrent Acute Myocardial Infarction: Missed Opportunities for Prevention? Arch Intern Med, March 22, 1999; 159(6): 561 - 567. [Abstract] [Full Text] [PDF]

				K S Spargias, A S Hall, D C Greenwood, and S G Ball beta Blocker treatment and other prognostic variables in patients with clinical evidence of heart failure after acute myocardial infarction: evidence from the AIRE study Heart, January 1, 1999; 81(1): 25 - 32. [Abstract] [Full Text]

				K. P. Alexander, E. D. Peterson, C. B. Granger, A. C. Casas, F. Van de Werf, P. W. Armstrong, A. Guerci, E. J. Topol, R. M. Califf, and for the GUSTO-IIB Investigators Potential impact of evidence-based medicine in acute coronary syndromes: insights from GUSTO-IIb J. Am. Coll. Cardiol., December 1, 1998; 32(7): 2023 - 2030. [Abstract] [Full Text] [PDF]

				T. J. Wang and R. S. Stafford National Patterns and Predictors of {beta}-Blocker Use in Patients With Coronary Artery Disease Arch Intern Med, September 28, 1998; 158(17): 1901 - 1906. [Abstract] [Full Text]

				H. M. Krumholz, M. J. Radford, Y. Wang, J. Chen, A. Heiat, and T. A. Marciniak National Use and Effectiveness of {beta}-Blockers for the Treatment of Elderly Patients After Acute Myocardial Infarction: National Cooperative Cardiovascular Project JAMA, August 19, 1998; 280(7): 623 - 629. [Abstract] [Full Text] [PDF]

				M. T. Donohoe Comparing Generalist and Specialty Care: Discrepancies, Deficiencies, and Excesses Arch Intern Med, August 10, 1998; 158(15): 1596 - 1608. [Abstract] [Full Text]

				H. V. Barron, S. Viskin, R. J. Lundstrom, B. E. Swain, A. F. Truman, C. C. Wong, and J. V. Selby {beta}-Blocker Dosages and Mortality After Myocardial Infarction: Data From a Large Health Maintenance Organization Arch Intern Med, March 9, 1998; 158(5): 449 - 453. [Abstract] [Full Text] [PDF]

				L. Tavazzi and A. Volpi Remarks About Postinfarction Prognosis in Light of the Experience With the Gruppo Italiano per lo Studio della Sopravvivenza nell' Infarto Miocardico (GISSI) Trials Circulation, March 4, 1997; 95(5): 1341 - 1345. [Full Text]

				S. B. Soumerai, T. J. McLaughlin, D. Spiegelman, E. Hertzmark, G. Thibault, and L. Goldman Adverse Outcomes of Underuse of {beta}-Blockers in Elderly Survivors of Acute Myocardial Infarction JAMA, January 8, 1997; 277(2): 115 - 121. [Abstract] [PDF]

				W. C. Felch and D. M. Scanlon Bridging the Gap Between Research and Practice: The Role of Continuing Medical Education JAMA, January 8, 1997; 277(2): 155 - 156. [Abstract] [PDF]